 |
市場調查報告書
商品編碼
1699463
同伴動物關節炎市場：依動物類型、適應症、治療方法、通路和地區Companion Animal Arthritis Market, By Animal Type, By Indication, By Treatment, By Distribution Channel, By Geography |
||||||
價格
簡介目錄
2025年全球同伴動物關節炎市場規模估計為 46.7億美元，預計到2032年將達到 78億美元，2025-2032年的年複合成長率（CAGR）為 7.6%。
| 報告範圍 | 報告詳細資訊 | ||
|---|---|---|---|
| 基準年 | 2024 | 2025年的市場規模 | 46.7億美元 |
| 歷史資料 | 2020-2024 | 預測期 | 2025-2032 |
| 預測期：2025-2032年年複合成長率： | 7.60% | 2032年價值預測 | 78億美元 |
圖表.同伴動物關節炎市場佔有率（%），依地區分類（2025年）
骨關節炎（OA）是一種影響狗和貓的常見疾病。其特徵是低度發炎進行性退化性關節疾病。骨關節炎是由關節軟骨的退化和異常修復引起的，與軟骨下骨骼代謝的改變、骨贅和滑膜發炎有關。在同伴動物中，OA 最常見的原因是關節鬆弛、骨軟骨症或創傷等潛在異常。這是一個包括骨膜纖維化和骨膜反應的病理過程，導致步態和運動範圍的改變。這會導致肌肉骨骼系統和次級關節穩定裝置的劣化，並由於異常負荷和磨損導致關節軟骨進一步劣化。
市場動態：
全球同伴動物關節炎市場主要受到新型治療藥物不斷增加的市場投放的推動。例如，加拿大衛生研究院（CIHR）資助了一項價值 60萬美元的電腦輔助設計（CAD）計劃，該計畫於2021年啟動，重點評估間質幹細胞治療犬骨關節炎的有效性。本研究將對患有肘部或距骨骨關節炎的顧客所擁有的狗進行一項隨機、雙盲、安慰劑對照的臨床試驗（來源：CIHR project funding）。這些研究的結果可能為新再生醫學的潛力提供有價值的見解。此外，先進治療方案的出現可能會鼓勵更多的飼主主人在獸醫的幫助下主動管理寵物的關節炎。預計這將在可預見的未來推動同伴動物關節炎市場的持續擴張。
本研究的主要特點
- 本報告對全球同伴動物關節炎市場進行了詳細分析，以2024年為基準年，並提供了預測期（2025-2032）的市場規模和年複合成長率（CAGR%）。
- 揭示不同領域的潛在商機，並解釋了該市場的有吸引力的投資提案矩陣。
- 提供有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
- 本報告根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數，概述了全球同伴動物關節炎市場的主要企業。
- 本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
- 全球同伴動物關節炎市場報告針對該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
- 相關人員將透過全球同伴動物關節炎市場分析中使用的各種策略矩陣更輕鬆地做出決策。
目錄
第1章 研究目的與前提
- 研究目標
- 先決條件
- 簡稱
第2章 市場展望
- 報告描述
- 市場定義和範圍
- 執行摘要
- Coherent Opportunity Map（COM）
第3章 市場動態、法規與趨勢分析
- 市場動態
- 影響分析
- 主要亮點
- 監管情景
- 服務產品組合
- PEST分析
- 波特分析
- 併購場景
- 管道分析
第4章 全球同伴動物關節炎市場-冠狀病毒（COVID-19）大流行的影響
- COVID-19流行病學
- 供需側分析
- 經濟影響
第5章 2020年至2032年全球同伴動物關節炎市場（依動物類型）
- 狗
- 貓
- 其他
第6章 2020年至2032年全球同伴動物關節炎市場（依適應症）
- 骨關節炎
- 其他關節炎
第7章 2020年至2032年全球同伴動物關節炎市場（依治療方法）
- 藥物
- NSAIDs
- 單株抗體
- 其他藥物
- 補充
- 其他治療方法
第8章 2020年至2032年全球同伴動物關節炎市場（依通路）
- 獸醫診所
- 零售藥局
- 網路商店
- 其他
第9章 2020年至2032年全球同伴動物關節炎市場（依地區）
- 北美洲
- 歐洲
- 亞太地區
- 拉丁美洲
- 中東
- 非洲
第10章 競爭格局
- Vetoquinol
- NexGen Pharmaceuticals
- Norbrook
- Eltech K-Laser srl
- Zoetis
- Virbac
- Elanco
- Boehringer Ingelheim International GmbH
- Ceva
- Dechra Pharmaceuticals PLC
- Others Prominent Players
第11章 章節
- 調查方法
- 關於出版商
簡介目錄
Product Code: CMI6525
Global Companion Animal Arthritis Market is estimated to be valued at USD 4.67 Bn in 2025 and is expected to reach USD 7.8 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.6% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 4.67 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 7.60% | 2032 Value Projection: | USD 7.8 Bn |
Figure. Companion Animal Arthritis Market Share (%), By Region 2025
Osteoarthritis (OA) is a common condition that affects dogs and cats. It is characterized as a low-grade inflammatory, progressive degenerative joint disease. OA results from degeneration and aberrant repair of articular cartilage in association with alterations in subchondral bone metabolism, osteophytosis, and synovial inflammation. In companion animals, OA is almost always secondary to an underlying abnormality, such as joint laxity, osteochondrosis, trauma, etc. It is a pathological process that includes joint capsule fibrosis and periosteal reactions, leading to an altered gait and range of motion. In turn, there is a deterioration of the musculoskeletal system and secondary joint stabilizers, resulting in further deterioration of articular cartilage due to abnormal loading and wear.
Market Dynamics:
The global companion animal arthritis market is mainly driven by the increasing development of novel therapeutics. For instance, the Canadian Institutes of Health Research (CIHR) funded a US$600,000 Computer-aided design (CAD) project launched in 2021 focused on evaluating the efficacy of mesenchymal stem cells for the treatment of osteoarthritis in dogs. The study involves a randomized, double-blinded, placebo-controlled clinical trial involving client-owned dogs with elbow or stifle osteoarthritis (source: CIHR project funding). Findings from these studies will provide valuable insights into the potential of new regenerative medicine options. Furthermore, the greater availability of advanced treatment choices will encourage more pet owners to actively manage their pet's arthritis with the help of veterinarians. This, in turn, will fuel ongoing expansion in the companion animal arthritis market beyond the foreseeable future.
Key features of the study:
- This report provides in-depth analysis of the global companion animal arthritis market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global companion animal arthritis market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Vetoquinol, NexGen Pharmaceuticals, Norbrook, Eltech K-Laser s.r.l, Zoetis, Virbac, Elanco, Boehringer Ingelheim International GmbH, Ceva, Dechra Pharmaceuticals PLC .
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global companion animal arthritis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global companion animal arthritis market
Global Companion animal arthritis Market Detailed Segmentation:
- By Animal Type
- Dogs
- Cats
- Others
- By Indication
- Osteoarthritis
- Other Arthritis
- By Treatment
- Medication
- NSAIDs
- Monoclonal Antibodies
- Others Medications
- Supplements
- Other Treatment
- By Distribution Channel
- Veterinary Hospitals & Clinics
- Retail Pharmacies
- Online Stores
- Others
- By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles
- Vetoquinol
- NexGen Pharmaceuticals
- Norbrook
- Eltech K-Laser s.r.l
- Zoetis
- Virbac
- Elanco
- Boehringer Ingelheim International GmbH
- Ceva
- Dechra Pharmaceuticals PLC
- Others Prominent Players .
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Companion Animal Arthritis Market, By Animal Type
- Global Companion Animal Arthritis Market, By Treatment
- Global Companion Animal Arthritis Market, By Indication
- Global Companion Animal Arthritis Market, By Distribution Channel
- Global Companion Animal Arthritis Market, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Rising Concerns About Self-Image and Confidence
- Side effects of treatment options
- Untapped emerging markets
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Service offering Portfolio
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Pipeline Analysis
4. Global Companion Animal Arthritis Market- Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
5. Global Companion Animal Arthritis Market, By Animal Type, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Dogs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Cats
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
6. Global Companion Animal Arthritis Market, By Indication, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Osteoarthritis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Other Arthritis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
7. Global Companion Animal Arthritis Market, By Treatment, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Medication
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- NSAIDs
- Monoclonal Antibodies
- Others Medications
- Supplements
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Other Treatments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
8. Global Companion Animal Arthritis Market, By Distribution Channel, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Veterinary Hospitals & Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Online Stores
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
9. Global Companion Animal Arthritis Market, By Region, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, By Country, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Country 2021 -2032
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Bn)
- North Africa
- Central Africa
- South Africa
10. Competitive Landscape
- Vetoquinol
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- NexGen Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Norbrook
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Eltech K-Laser s.r.l
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Zoetis
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Virbac
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Elanco
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Boehringer Ingelheim International GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Ceva
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Dechra Pharmaceuticals PLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Others Prominent Players
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
11. Section
- Research Methodology
- About us
